Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study. - Wikidata - awgldk - TriplyDB

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

http://www.wikidata.org/entity/Q34974404

about

Current management of autosomal dominant polycystic kidney disease A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease.Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians.Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study.Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.Health-related quality of life across all stages of autosomal dominant polycystic kidney disease.Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease.Hepatointestinal complications in polycystic kidney disease.European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants.The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health.Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment.

P2860

Q26784073-1970A963-6C4C-4C5B-80E3-10EA6603C0F1 Q30204911-4ED2BFE5-ED07-423D-8251-4981B159DB48 Q33730091-9BE0351F-5DC8-4411-A2A3-46AF0514B1DE Q33873089-85342083-BFF2-4E29-9345-635F984921F2 Q35682187-4C6CE87A-25C9-40DE-8734-E2F303260CD8 Q35862300-10309957-C801-4DD7-8855-017172CD68B2 Q36088863-9374CDE8-7C18-4704-BFD4-05F1BFE07CF5 Q36187889-2D531975-0184-43DC-B9D5-F7645DEB391A Q37051977-9C53D1E1-1504-484B-A2AB-83DFDF73B56D Q38618900-ED97A1AB-072C-4E47-9F3E-9E6D22789D13 Q38960067-904D6C4E-F26A-4C49-B3D7-83B56DF4625D Q39357028-FEEA1DF3-DA0A-4D66-81E8-3C094D4198E6 Q40040634-22206151-8155-46C2-9FF0-27B083245A5A Q45858469-E3CE0C38-15F9-4D2A-9E94-DE207337F39C Q47564027-19406E7D-B027-4FD2-9EF4-7A5CD6A5C595 Q47648297-2A65BC93-EB8D-42F2-965B-4C5B9D801E56 Q47858439-A9B457B7-97A0-4E2F-B76C-89AE1736233E Q48055079-6F0CD8DF-675E-4321-A9BA-416D7CE7E143 Q50024807-DDA27E70-2227-4C47-A6B2-AE05A2664986

P2860

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

http://www.wikidata.org/entity/Q34974404

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@ast

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@en

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@nl

type

label

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@ast

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@en

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@nl

prefLabel

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@ast

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@en

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@nl

P1433

Q34974404-2367D058-C0FE-49E9-A21E-86B3C030FA66

P1476

Q34974404-EC7F43A6-DBDF-4451-91CB-4975103C17B7

P2093

Q34974404-3CA0ABE5-A0E0-4A76-A93E-E38CBD22C110

Q34974404-45B51379-6F11-407F-8AD6-D7772EDDF3B4

Q34974404-482BB00E-7AFA-4679-9C7B-BF7B0A2D9C4C

Q34974404-484A3CEE-9052-433A-9030-ECF8A8764C31

Q34974404-5D676258-CE58-4BA9-946F-50EDB1703AA3

Q34974404-744068B1-85D3-4E2C-B77F-6D547FB5896F

Q34974404-7FDD4D03-6E8B-4575-BE48-B9EC4491031F

Q34974404-875219EB-D810-4F59-ADC7-F6B1794F0C80

Q34974404-8FCCEC29-2C06-4635-8A69-E5A49E91BF7B

Q34974404-B46C55C6-6043-4F36-8F91-281F6EA7460A

P2860

Q34974404-08292617-5B4C-4A57-A368-72EB090F7F90

Q34974404-29E6B788-A61B-4972-919F-19E081BC9C73

Q34974404-48CC98B0-0E88-478E-B1DA-51DE69CB5693

Q34974404-4E55041E-7B55-4408-A9AF-CB312909468C

Q34974404-8A7E6E10-9F7E-4722-AD6A-2A8BB15F8C3B

Q34974404-8C68C388-096B-47D0-96C8-673B605544CB

Q34974404-A576F53B-6774-4C88-BE42-9E7381E6C087

Q34974404-C0A64E86-4F76-4F70-9195-BF9A47FBBB03

Q34974404-C54BC3A7-D061-41CA-A66B-799FAC96D43F

Q34974404-C83671BF-F57D-4864-BD8F-7A1785E3E5D9

P304

Q34974404-BA11AE13-98DB-4E0A-85A6-A3DCB2E8A61A

P31

Q34974404-4A507ACE-EC5E-4039-B126-F46E54C9B554

P356

Q34974404-95FDA7DB-1619-4861-9E7A-ADFED263B856

P478

Q34974404-2CBFB37C-BD74-4207-9BB6-BD56E4A5F9C3

P577

Q34974404-3362829E-48B1-4E0A-AE77-F89BA25D725F

P5875

Q34974404-ADC53989-B8E2-4ABB-BF56-CB589CD6203D

P698

Q34974404-36D87DF2-29D3-42D1-AFA7-E7C1F9E7DF92

P921

Q34974404-5F5CA42E-087F-4066-846C-50E9463592E3

P932

Q34974404-938C5E25-870A-4664-B7DD-87F8D5DD62EE

P356

1471-2369-14-179

P1433

P1476

Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.

@en

P2093

Eiko Hasegawa

http://www.w3.org/2001/XMLSchema#string

Junichi Hoshino

http://www.w3.org/2001/XMLSchema#string

Keiichi Sumida

http://www.w3.org/2001/XMLSchema#string

Kenmei Takaichi

http://www.w3.org/2001/XMLSchema#string

Koki Mise

http://www.w3.org/2001/XMLSchema#string

Masahiro Kawada

http://www.w3.org/2001/XMLSchema#string

Masayuki Yamanouchi

http://www.w3.org/2001/XMLSchema#string

Naoki Sawa

http://www.w3.org/2001/XMLSchema#string

Noriko Hayami

http://www.w3.org/2001/XMLSchema#string

Rikako Hiramatsu

http://www.w3.org/2001/XMLSchema#string

P2860

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Pain management in polycystic kidney disease.

Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis

Psychological factors affecting end-stage renal disease. A review.

Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients.

"An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.

Polycystic kidney disease re-evaluated: a population-based study.

Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey.

Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.

Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.

P304

179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2369-14-179

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256118536

http://www.w3.org/2001/XMLSchema#string

P698

23978051

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3765978

http://www.w3.org/2001/XMLSchema#string